GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zoetis Inc (NYSE:ZTS) » Definitions » Shiller PE Ratio
中文

Zoetis (Zoetis) Shiller PE Ratio : 46.28 (As of Apr. 25, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Zoetis Shiller PE Ratio?

As of today (2024-04-25), Zoetis's current share price is $150.88. Zoetis's E10 for the quarter that ended in Dec. 2023 was $3.26. Zoetis's Shiller PE Ratio for today is 46.28.

The historical rank and industry rank for Zoetis's Shiller PE Ratio or its related term are showing as below:

ZTS' s Shiller PE Ratio Range Over the Past 10 Years
Min: 44.94   Med: 68.19   Max: 110.74
Current: 46.28

During the past years, Zoetis's highest Shiller PE Ratio was 110.74. The lowest was 44.94. And the median was 68.19.

ZTS's Shiller PE Ratio is ranked worse than
79.96% of 514 companies
in the Drug Manufacturers industry
Industry Median: 24.47 vs ZTS: 46.28

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Zoetis's adjusted earnings per share data for the three months ended in Dec. 2023 was $1.140. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $3.26 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Zoetis Shiller PE Ratio Historical Data

The historical data trend for Zoetis's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zoetis Shiller PE Ratio Chart

Zoetis Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 91.65 105.75 52.46 60.47

Zoetis Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 52.46 56.92 56.16 54.57 60.47

Competitive Comparison of Zoetis's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Zoetis's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zoetis's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zoetis's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Zoetis's Shiller PE Ratio falls into.



Zoetis Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Zoetis's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=150.88/3.26
=46.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zoetis's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Zoetis's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=1.14/129.4194*129.4194
=1.140

Current CPI (Dec. 2023) = 129.4194.

Zoetis Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 0.310 99.695 0.402
201406 0.270 100.560 0.347
201409 0.330 100.428 0.425
201412 0.250 99.070 0.327
201503 0.330 99.621 0.429
201506 -0.070 100.684 -0.090
201509 0.380 100.392 0.490
201512 0.040 99.792 0.052
201603 0.410 100.470 0.528
201606 0.450 101.688 0.573
201609 0.480 101.861 0.610
201612 0.310 101.863 0.394
201703 0.480 102.862 0.604
201706 0.500 103.349 0.626
201709 0.610 104.136 0.758
201712 0.160 104.011 0.199
201803 0.720 105.290 0.885
201806 0.790 106.317 0.962
201809 0.710 106.507 0.863
201812 0.710 105.998 0.867
201903 0.650 107.251 0.784
201906 0.770 108.070 0.922
201909 0.900 108.329 1.075
201912 0.800 108.420 0.955
202003 0.880 108.902 1.046
202006 0.790 108.767 0.940
202009 1.000 109.815 1.179
202012 0.750 109.897 0.883
202103 1.170 111.754 1.355
202106 1.070 114.631 1.208
202109 1.160 115.734 1.297
202112 0.870 117.630 0.957
202203 1.260 121.301 1.344
202206 1.120 125.017 1.159
202209 1.130 125.227 1.168
202212 0.990 125.222 1.023
202303 1.190 127.348 1.209
202306 1.450 128.729 1.458
202309 1.290 129.860 1.286
202312 1.140 129.419 1.140

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Zoetis  (NYSE:ZTS) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Zoetis Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Zoetis's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Zoetis (Zoetis) Business Description

Address
10 Sylvan Way, Parsippany, NJ, USA, 07054
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Executives
Roxanne Lagano officer: Executive Vice President C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054
Kristin C Peck officer: Executive Vice President C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054
Heidi C. Chen officer: Executive Vice President C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054
Robert J Polzer officer: Executive Vice President C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054
Soria Ester Banque officer: Executive Vice President C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054
Rimma Driscoll officer: Executive Vice President C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054
Jamie Brannan officer: Executive Vice President C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054
Vanessa Broadhurst director ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK NJ 08933
Willie M Reed director C/O ZOETIS, 100 CAMPUS DRIVE, FLORHAM PARK NJ 07932
Nicholas Ashton officer: Executive Vice President C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054
Roman Trawicki officer: Executive Vice President C/O ZOETIS INC., 100 CAMPUS DRIVE, FLORHAM PARK NJ 07932
Glenn David officer: SVP and Acting CFO C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054
Astorga Jeannette Ferran officer: Executive Vice President C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054
Catherine A. Knupp officer: Executive Vice President C/O ZOETIS INC., 100 CAMPUS DRIVE, FLORHAM PARK NJ 07940
Gregory Norden director 16640 CHESTERFIELD GROVE DRIVE, SUITE 200, CHESTERFIELD MO 63005

Zoetis (Zoetis) Headlines

From GuruFocus

Q1 2023 Zoetis Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q4 2022 Zoetis Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Zoetis Inc at Jefferies Pet Summit (Virtual) Transcript

By GuruFocus Research 01-23-2024

Q2 2023 Zoetis Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Zoetis Inc Annual Shareholders Meeting Transcript

By GuruFocus Research 01-23-2024

Zoetis Inc at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 01-23-2024

Zoetis Inc Investor Day Transcript

By GuruFocus Research 01-23-2024